Showing results (101-110 of 114) with videos related to

Sort By:
Pageof 12
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|August 27, 2022
Patient-reported tolerability of adjuvant ipilimumab (3 or 10 mg/kg) versus high-dose interferon alfa-2b for resected high-risk stage III-IV melanoma in phase III trial E1609Laurie E McLouth, Yue Zheng, Stephanie Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 24, 2024
Utility of the 70-Gene MammaPrint Assay for Prediction of Benefit From Extended Letrozole Therapy in the NRG Oncology/NSABP B-42 TrialPriya Rastogi, Hanna Bandos, Peter C Lucas, et al.
Pharmacogenomics|August 24, 2023
Effects of <i>CYP3A4</i> and <i>CYP2C9</i> genotype on systemic anastrozole and fulvestrant concentrations in SWOG S0226Delaney V Rutherford, Sarah Medley, Nicholas C Henderson, et al.
Addictive Behaviors|September 3, 2005
The prevalence of weight concerns in a smoking abstinence clinical trialMatthew M Clark, Richard D Hurt, Ivana T Croghan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 8, 2015
Phase II Study of Gemcitabine, Carboplatin, and Iniparib As Neoadjuvant Therapy for Triple-Negative and BRCA1/2 Mutation-Associated Breast Cancer With Assessment of a Tumor-Based Measure of Genomic Instability: PrECOG 0105Melinda L Telli, Kristin C Jensen, Shaveta Vinayak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 8, 2021
Nivolumab and Ipilimumab as Maintenance Therapy in Extensive-Disease Small-Cell Lung Cancer: CheckMate 451Taofeek K Owonikoko, Keunchil Park, Ramaswamy Govindan, et al.
The New England Journal of Medicine|March 5, 2015
Goserelin for ovarian protection during breast-cancer adjuvant chemotherapyHalle C F Moore, Joseph M Unger, Kelly-Anne Phillips, et al.
Pageof 12